Single Pass, Inc. has developed the Kronos Electrocautery device, which is the first patented disposable electrocautery tool designed specifically for use in biopsy procedures. This innovative device addresses the significant issue of bleeding complications that can arise during solid organ biopsies, particularly in patients with blood disorders or those on anticoagulation medication. By safely cauterizing deep tissue through a guide needle, the Kronos device enhances the safety of these procedures, allowing for the use of larger needles to obtain more substantial tissue samples while minimizing the risk of post-biopsy hemorrhaging. This technology not only improves patient outcomes but also has the potential to reduce overall procedure costs by decreasing the need for additional medications and extended hospital stays.

The Kronos Electrocautery device is designed to be portable, disposable, and battery-powered, eliminating the need for bulky generators typically associated with electrocautery devices. Its compatibility with all guide needles and its ability to efficiently seal biopsy channels make it a versatile tool for healthcare providers. The device has been positively reviewed by medical professionals, who note its effectiveness in reducing bleeding risks and enhancing confidence in performing biopsies on high-risk patients. Overall, Single Pass, Inc. aims to revolutionize biopsy procedures with this groundbreaking technology, ultimately improving the safety and efficiency of patient care.

United States

The Kronos Electrocautery device efficiently seals biopsy channels, enhancing safety for high-risk patients and enabling the use of larger needles for more substantial tissue samples in few
\er passes. Its usage may reduce procedure costs by eliminating the need for certain medications, hemostatic agents, and post-procedure observation.

Single Pass, Inc.

Company Details